To establish a basis for a possible strategy for bone marrow ablation or therapy, we examined the effect of bromodeoxyuridine (BrdU) incorporation into DNA on the genotoxic and cytotoxic effects of samarium-153 ethylenediaminetetramethylene phosphonate (153Sm-EDTMP) in normoblasts in vivo. Cytotoxicity and genotoxicity were established by time–response curves of polychromatic erythrocyte (PCE) and micronucleated polychromatic erythrocyte (MN-PCE) frequencies, respectively, in mouse peripheral blood samples. The group treated with 153Sm-EDTMP showed a clear induction of MN-PCEs; however, the group treated with BrdU plus 153Sm-EDTMP paradoxically showed only a slight increase with respect to untreated controls. Treatment with 53Sm-EDTMP caused a small reduction in PCE frequency, but exposure to BrdU or to BrdU plus 53Sm-EDTMP reduced the PCE frequency significantly from 32 h to the end of the experiment. The PCE frequencies in the BrdU plus 53Sm-EDTMP group were significantly lower than in the BrdU control group at the final time and were much lower than the group treated with only 53Sm-EDTMP, which returned to basal values. The results suggest the radioinduction of a lethal lesion in BrdU-substituted DNA that cannot be repaired easily and does not permit cell division and micronucleus formation.
How to translate text using browser tools
28 January 2010
Radiosensitization of Murine Normoblasts In Vivo by Bromodeoxyuridine to the Genotoxicity and Cytotoxicity of the Bone-Seeking Radiopharmaceutical 153Sm-EDTMP
E. Morales-Ávila,
G. Ferro-Flores,
T. Vallarino-Kelly,
P. Morales-Ramírez
ACCESS THE FULL ARTICLE